Company Cannara Biotech Inc. Canadian Securities Exchange

Equities

LOVE

CA13765U1012

Healthcare Facilities & Services

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sales per region

Sector Medical Farming

Delayed Canadian Securities Exchange Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	+87.50%

Jan. 29	Cannara Biotech Inc. Reports Earnings Results for the First Quarter Ended November 30, 2023	CI
2023	Cannara Biotech Inc. Reports Earnings Results for the Full Year Ended August 31, 2023	CI

Cannara Biotech Inc. is a Canada-based vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. It operates through its wholly owned subsidiaries, Cannara Biotech (Quebec) Inc. and Cannara Biotech (Valleyfield) Inc. The Company owns two mega facilities based in Quebec spanning over 1,650,000 square feet, providing the Company with 100,000 kilograms of annualized cultivation output. It operates in two segments: Cannabis operations and Real estate operations. The Cannabis operations, which encompasses the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and other cannabis services (Cannabis operations). The Real estate operations, related to the Farnham and Valleyfield building (Real estate operations). The Companyâs brand portfolio includes Tribal, Nugz, and Orchid CBD. Orchid CBD is a wellness brand that provides premium CBD-dominant cannabis.

CAD in Million	2022	Weight	2023	Weight	Delta
Cannabis 100.0 %	28	99.9 %	52	100.0 %	+83.52%

CAD in Million	2022	Weight	2023	Weight	Delta
Canada 100.0 %	28	99.9 %	52	100.0 %	+83.52%

Managers	Title	Age	Since
Zohar Krivorot CEO	Chief Executive Officer	48	18-12-30
Nicholas Sosiak DFI	Director of Finance/CFO	-	19-03-31
Avi Krivorot CTO	Chief Tech/Sci/R&D Officer	-	21-03-31
Anthony Manouk CMP	Compliance Officer	-	18-10-31
France Landry HRO	Human Resources Officer	-	19-03-31
Scott Carroll SAM	Sales & Marketing	-	22-02-28
Brian Sherman LAW	General Counsel	-	21-09-30
Noemi Follain AUD	Comptroller/Controller/Auditor	-	19-12-31

Members of the board	Title	Age	Since
Jacob M. Kay BRD	Director/Board Member	83	19-05-24
Donald Olds BRD	Director/Board Member	64	20-11-09
Zohar Krivorot CEO	Chief Executive Officer	48	18-12-30
Derek Stern BRD	Director/Board Member	57	18-12-30
Mary Durocher BRD	Director/Board Member	-	20-05-24

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	90,018,952	45,531,555 ( 50.58 %)	0	50.58 %

Name	Equities	%	Valuation
Zohar Krivorot 26.95 %	24,258,982	26.95 %	17 M $
Derek Stern 22.32 %	20,090,797	22.32 %	14 M $
Jacob M. Kay 0.2433 %	219,000	0.2433 %	150 015 $
Nicholas Sosiak 0.2331 %	209,795	0.2331 %	143 710 $
Brian Sherman 0.1296 %	116,700	0.1296 %	79 940 $
Donald Olds 0.1284 %	115,562	0.1284 %	79 160 $
Avi Krivorot 0.0525 %	47,250	0.0525 %	32 366 $
Scott Carroll 0.003449 %	3,105	0.003449 %	2 127 $
Mary Durocher 0.000000 %	0	0.000000 %	- $
Noemi Follain 0.000000 %	0	0.000000 %	- $

Cannara Biotech, Inc.

333 Décarie Boulevard Suite 200

+514-543-4200

http://www.cannara.ca

Healthcare

Healthcare Services

Healthcare Providers & Services

Healthcare Facilities & Services

Medical Farming

	1st Jan change	Capi.
ASCEND WELLNESS HOLDINGS, INC.	+31.96%	291M
AYR WELLNESS INC.	+38.27%	274M
ORGANIGRAM HOLDINGS INC.	+54.65%	203M
JUSHI HOLDINGS INC.	+48.33%	133M
THE CANNABIST COMPANY HOLDINGS INC.	-39.97%	122M
IANTHUS CAPITAL HOLDINGS, INC.	-28.57%	121M
INTERCURE LTD.	+114.27%	114M
BAKHU HOLDINGS, CORP.	+150.00%	75.33M
4FRONT VENTURES CORP.	-23.08%	70.21M

Medical Farming